Prosecution Insights
Last updated: October 04, 2026

Ainos Inc.

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready

Analysis

Ainos Inc. currently has 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are split among 3 distinct examiners, providing a diverse set of reviews for the company's medical innovations. The portfolio is spread across 2 distinct art units, which suggests that the 3 pending office actions involve different specialized sub-fields. This distribution requires the company to navigate the unique examination cultures of 2 distinct art units simultaneously.

KIM, SAMUEL CHONG is the busiest examiner, responsible for 1 busiest examiner pending action. With 3 pending office actions and 3 distinct examiners, the workload is perfectly distributed. This lack of concentration prevents any single examiner from having a disproportionate influence on the portfolio's outcomes. However, the involvement of 2 distinct art units means that the prosecution team must be prepared for different technical benchmarks. Successfully managing these 3 pending office actions will require a flexible approach that addresses the specific concerns of the 3 distinct examiners while maintaining overall portfolio consistency.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (33%)
2
Medium (67%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (33%)
§102 only1 (33%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
33% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
33% of docket
1
Business / Other
33% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KIM, SAMUEL CHONG 1 48.7% +70.4%
TRUONG, QUANGLONG N 1 78.8% +23.6%
ABBAS, SYED JARAR 1 0.0% +0.0%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18140535 METHOD AND COMPOSITION OF TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION ABBAS, SYED JARAR 5d overdue
18771339 Portable kit and device for detecting or identifying diseases or disorders in a human subject by collecting biological sample from the human subject KIM, SAMUEL CHONG —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18771339 Portable kit and device for detecting or identifying diseases or disorders in a human subject by collecting biological sample from the human subject KIM, SAMUEL CHONG —
18733102 PROCESS FOR MANUFACTURING ORALLY DISINTEGRATING TABLET COMPRISING CYTOKINE TRUONG, QUANGLONG N —

Top Art Units

Art UnitApps
3791 1
1674 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18771339 Portable kit and device for detecting or identifying diseases or disorders in a human subject by collecting biological sample from the human subject KIM, SAMUEL CHONG 3791 §103§112 Non-Final OA — Pending Jul 12, 2024
18733102 PROCESS FOR MANUFACTURING ORALLY DISINTEGRATING TABLET COMPRISING CYTOKINE TRUONG, QUANGLONG N — §103 Non-Final OA — Pending Jun 04, 2024
18140535 METHOD AND COMPOSITION OF TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION ABBAS, SYED JARAR 1674 §102 Final Rejection 5d overdue Pending Apr 27, 2023

Managing Ainos Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month